For example, studies that demonstrate D&Q improved obesity‐associated glucose tolerance did not report any findings on hepatic gluconeogenesis and one study indicated that insulin sensitivity was improved (Palmer et al., 2019; Sierra‐Ramirez et al., 2020). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.